1. Home
  2. MC vs LNTH Comparison

MC vs LNTH Comparison

Compare MC & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MC
  • LNTH
  • Stock Information
  • Founded
  • MC 2007
  • LNTH 1956
  • Country
  • MC United States
  • LNTH United States
  • Employees
  • MC N/A
  • LNTH N/A
  • Industry
  • MC Investment Managers
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • MC Finance
  • LNTH Health Care
  • Exchange
  • MC Nasdaq
  • LNTH Nasdaq
  • Market Cap
  • MC 4.2B
  • LNTH 3.6B
  • IPO Year
  • MC 2014
  • LNTH 2015
  • Fundamental
  • Price
  • MC $72.08
  • LNTH $54.18
  • Analyst Decision
  • MC Hold
  • LNTH Strong Buy
  • Analyst Count
  • MC 7
  • LNTH 6
  • Target Price
  • MC $66.00
  • LNTH $105.50
  • AVG Volume (30 Days)
  • MC 845.4K
  • LNTH 2.0M
  • Earning Date
  • MC 07-24-2025
  • LNTH 08-06-2025
  • Dividend Yield
  • MC 3.59%
  • LNTH N/A
  • EPS Growth
  • MC 1309.15
  • LNTH N/A
  • EPS
  • MC 2.67
  • LNTH 3.77
  • Revenue
  • MC $1,384,443,000.00
  • LNTH $1,520,653,000.00
  • Revenue This Year
  • MC $24.90
  • LNTH $4.57
  • Revenue Next Year
  • MC $17.16
  • LNTH $9.41
  • P/E Ratio
  • MC $27.10
  • LNTH $14.36
  • Revenue Growth
  • MC 42.85
  • LNTH 5.75
  • 52 Week Low
  • MC $47.00
  • LNTH $47.25
  • 52 Week High
  • MC $82.89
  • LNTH $118.21
  • Technical
  • Relative Strength Index (RSI)
  • MC 57.49
  • LNTH 28.58
  • Support Level
  • MC $68.78
  • LNTH $51.40
  • Resistance Level
  • MC $75.10
  • LNTH $57.21
  • Average True Range (ATR)
  • MC 1.61
  • LNTH 2.26
  • MACD
  • MC 0.02
  • LNTH -1.06
  • Stochastic Oscillator
  • MC 65.39
  • LNTH 26.18

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: